[Sudden cardiac death and decompensation of heart failure: how to reduce the risks. A review]
Related Experiment Video
Updated: May 13, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
M V Kuleshova1, T M Uskach2,3, O V Sapelnikov2
1National Medical Research Center for High Medical Technologies - Vishnevsky Central Military Clinical Hospital.
Insights
Sudden cardiac death and heart failure (HF) decompensation are leading causes of mortality. Implantable devices with multisensory monitoring show promise in early detection and prevention of HF decompensation, potentially reducing hospitalizations and improving survival.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Sudden cardiac death and heart failure (HF) decompensation are primary causes of mortality in HF patients, particularly those with reduced left ventricular ejection fraction.
- Predicting and preventing these adverse events are critical for both medical and electrophysiological management strategies.
Purpose of the Study:
- To review clinical studies on implantable cardioverter defibrillators (ICDs) for sudden cardiac death prevention in HF.
- To highlight the role of multisensory monitoring in implantable devices for early detection of HF decompensation.
Main Methods:
- Overview of clinical studies on ICDs in HF.
- Focus on implantable devices with advanced multisensory capabilities for HF monitoring.
Main Results:
- ICDs are established for sudden cardiac death prevention.
- Multisensory monitoring in implantable devices enables early detection of impending HF decompensation before overt symptoms arise.
Conclusions:
- Multisensory monitoring in implantable devices offers a novel approach to proactively manage HF.
- This technology is expected to decrease HF exacerbations, reduce hospitalizations, and ultimately lower mortality rates in HF patients.
Abstract:
The main causes of death in patients with heart failure (HF) are sudden cardiac death and decompensation of HF, especially with a low left ventricular ejection fraction. The prediction and prevention of risk factors for the development of these conditions are important goals both for guideline-directed medical therapy and for electrophysiological treatment methods. The article presents an overview of clinical studies devoted to the study of implantable cardioverter defibrillators in the prevention of sudden cardiac death, highlights the issues of monitoring the course of HF. Special attention is paid to multisensory monitoring in implantable devices equipped with a unique set of sensors for early diagnosis of the development of HF decompensation. It is expected that the practical use of such devices will reduce the number of exacerbations and hospitalizations for HF by detecting signs of threatening decompensation of blood circulation before the appearance of active symptoms, and as a result will reduce mortality in this category of patients.
More Related Videos
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Pathophysiology of Heart Failure
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...